Mid-Term Clinical Outcomes and Hemodynamic Performances of Trifecta and Perimount Bioprostheses following Aortic Valve Replacement.

J Cardiovasc Dev Dis · 2023 · PMC10146805 · PMID 37103018

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

At the latest follow-up, the Trifecta valve only maintained a better mean gradient for the 25 mm valve, and for all other sizes, we observed an increasing trend which persisted in the weighted analysis populations.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.